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Summary 
The T cell receptor (TCR) can interact with a spectrum 
of peptides as part of its ligand, including the immuno- 
genic peptide, variants of this peptide, and apparently 
unrelated peptides. The basis of this broad specificity 
for ligand was investigated by substitution analysis of 
a peptlde antigen and functlonal testing using a B cell 
apoptosis assay. A peptlde containing as few as 1 aa 
in common with this peptide could stimulate a specific 
T cell response. Two endogenous ligands, an agonist 
and a partial agonist, were readily identified from a 
search of the SwissProt database, indicating that mul- 
tiple endogenous ligands likely exist for a given T cell. 
These findings strongly support the concept that one 
TCR has the ability to interact productively wlth multi- 
ple different ligands, and provide evidence that such 
ligands exist In the endogenous peptide repertoire. 
Introduction 
While the recognition of peptide antigen by T cells via the 
T cell receptor (TCR) has exquisite specificity, numerous 
studies have unequivocally shown a flexibility in this recog- 
nition (Evavold and Allen, 1991; De Magistris et al., 1992; 
Sette et al., 1994; Evavold et al., 1993b). This has been 
demonstrated as productive interactions with less than 
optimal ligands, resulting in functional activation, anergy, 
or antagonism of peripheral T cells (Evavold and Allen, 
1991; Evavold et al., 1993c; Sloan-Lancaster et al., 1993, 
1994a; Racioppi et al., 1993) or as positive and negative 
selection of thymocytes (Hogquist et al., 1994; Ashton- 
Rickardt et al., 1994; Vasquez et al., 1994; Spain et al., 
1994). These findings imply that a single TCR can produc- 
tively interact with several different ligands, which can be 
classified as agonists, partial agonists, and antagonists 
for the T cell. 
Related to this productive recognition of less than opti- 
mal ligands is the phenomenon of cross-reactive immune 
responses. These were initially observed for antibodies 
(Landsteiner, 1917) and subsequently shown for T cells. 
Many of the initial studies showing T cell cross-reactive 
responses involved defined haptens such as arsonate (Na- 
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lefski and Rao, 1993), fluorescein (Siliciano et al., 1986) 
and trinitrophenol (Clayberger et al., 1983). Multiple stud- 
ies have shown cross-reactivity between two peptides in 
which there is clear sequence homology (Cao et al., 1994; 
Wraith et al., 1992; Luo et al., 1993; Guillet et al., 1987; 
Anderson et al., 1988; Fujinami and Oldstone, 1985) or in 
which chimeric peptides were generated by a systematic 
transfer of key amino acid residues (Rothbard et al., 1988; 
Lorenz et al., 1989). However, several reports have also 
demonstrated that apparently unrelated peptides are able 
to stimulate the same TCR. These include T cells specific 
for myelin basic protein (Bhardwaj et al., 1993) and human 
al-anti-trypsin (D. T. Hagerty and P. M. A., submitted). 
While the phenomenon of T cell cross-reactivity has been 
firmly established, the molecular basis of how two unre- 
lated peptides can stimulate the same T cell remains to 
be elucidated. Furthermore, whether the recognition of 
cross-reactive determinants is a feature of only a small 
subset of T cells or a fundamental property of all T cells 
is not known. 
In these studies, we wanted to investigate the ability of 
the TCR to recognize a variety of different ligands and to 
establish the rules for such interactions. To accomplish 
this, a sensitive assay was employed involving apoptosis 
of a B cell line, which could detect both agonists and partial 
agonists for a defined TCR. Our findings revealed that a 
single amino acid in common with the native ligand, in 
combination with acceptable substitutions at TCR and ma- 
jor histocompatibility complex (MHC) contact sites, was 
sufficient to allow a productive interaction between the 
peptide and TCR. Having established the rules for peptide 
recognition, we then wanted to ascertain whether natural 
agonists or partial agonists exist in the endogenous pep- 
tide repertoire. A search of the SwissProt database readily 
identified both a natural agonist and a partial agonist pep- 
tide for T cells expressing this TCR. The identification of 
possible endogenous ligands has important implications 
in several areas of T cell biology, including involvement 
in thymocyte development, generation of cross-reactive 
responses, autoimmunity, and the maintenance of T cell 
memory. 
Results 
Apoptosls Assay Identifies Agonist and Parhal 
Agonist Peptides 
To identify agonist and partial agonist peptides for a spe- 
cific TCR, we needed a sensitive assay for activating li- 
gands and a set of rules for peptide recognition by the 
TCR. A rapid and sensitive assay for the interaction of 
TCR with agonist and partial agonist peptide ligands was 
developed that relied on the induction of apoptosis in a B 
cell lymphoma (CH27) by T helper-l (Thl) clones (Figure 
1A). The CD4-dependent PL.17 Thl clone induced B cell 
lymphoma apoptosis in a dose-dependent and peptide 
specific manner (Figure lA), with the induction of apop- 
tosis confirmed as the characteristic ladder of DNA frag- 
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Figure 1. Apoptosis of CH27 B Cell Lymphoma Mediated by the PL.17 
Thl Clone 
(A) Peptides known to be agonists (Hb[64-761, S74) and partial ago- 
nists (S70, D73) for the PL.17 Thl clone induced CH27 apoptosis. The 
agonists (closed symbols) and partial agonists (half-closed symbols) 
could be distinguished by comparing the concentration of peptide that 
resulted in 50% apoptosis (t?&). The shaded portions of the graph 
indicate the area where the ECU values for agonist and partial agonists 
are found. The border between the agonists and partial agonistsvaries 
slightly between 0.1 and 1 PM; however, partial agonists never had 
an ECso < 1 WM. Results are shown as the percent of apoptosis, which 
was calculated as (1 .O - [sample CPMKH27 control CPM]) x 100. 
In this experiment, the CH27 control (CH27 plus Thl and no peptide) 
gave 16,246 cpm. The values represent the mean of duplicate determi- 
nations. The standard deviations are for each point was <lo% of the 
mean value. These results are representative of 32 different experi- 
ments. 
(B) DNAfragmentation of the CH27 cells wasvisualized by agarose gel 
electrophoresis. This experiment was performed twice, with identical 
results. 
mentation (Figure 16). This apoptosis was mediated by 
cell to cell contact and not by a soluble mediator (data not 
shown). However, it is unknown whether this apoptosis 
involves FAS-FAS ligand interactions or is occurring via 
TCR 
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Figure 2. Anatomy of the Hb(64-76) Determinant 
The amino acid sequence of Hb(64-76) and the wellcharac srized 
moth cytochrome c (93-103) Th determinants were aligned by their 
MHC anchor residues(boxed), leading to the alignment of their primary 
T cell contact residues (large arrow). The secondary TCR contact resi- 
dues of Hb(64-76) are indicated by the smaller arrows. Other side 
chains and main chain atoms are involved in the binding of Hb(64- 
76) to the I-EL molecule; however, they are not indicated for clarity. 
The core sequence of the Hb(64-76), residues 67-76, are in bold, 
whereas flanking residues 64,65.66,77. and 76 are shown in standard 
type. 
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The generation of activating ligands for PL.17 were determined 
by the CH27 apoptosis assay. For the PL.17 clone, none of the 19 aa 
substitutions at position 72 were agonists or partial agonists, support- 
ing the primary nature of this amino acid. At position 70, again none 
of the 19 variant ligands retained agonist activity, but C, D, F, G, I. L, 
M, P. S, T, V, W, or Y residues at position 70 were partial agonists. 
For position 69 an S substitution was an agonist, and P or F were 
partial agonists. For position 73, A, Et, or 0 were agonists and D was 
a partial agonist. For position 75, I was an agonist and V was a partial 
agonist. Agonist and partial agonists were identified by their EC& val- 
ues and agonist activity was confirmed using proliferation assays. All 
peptides were tested at least twice at various concentrations, with the 
maximal concentration being 100 uM. 
a different mechanism (Nagata and Golstein, 1995). Both 
agonist and partial agonist ligands induced apoptosis in 
these experiments (Sloan-Lancaster et al., 1993; Evavold 
et al., 1992) yet they could be clearly differentiated by 
determining the E& for a given peptide (Figure 1A). 
Therefore, a peptide could be classified as either an ago- 
nist or partial agonist based on its potency in the apoptosis 
assay. To date, the apoptosis assay has been tested using 
15 agonists and 15 partial agonists with the results directly 
correlated to those from the proliferation (agonist) and an- 
ergy (partial agonist) assays (data not shown). The advan- 
tage of the apoptosis assay is the speed with which one 
can classify the peptides, as it takes only 24 hr instead 
of 3-7 days to determine results and appropriately classify 
the peptides. In addition, the apoptosis assay is more-sen- 
sitive than the other assays in that it required less peptide 
(>lOO-fold). Thus, the induction of CH27 apoptosis pro- 
vided a sensitive and rapid assay for identifying agonist 
or partial agonist peptides. 
Anatomy of the Hb(64-76)/l-E’ Determinant 
Numerous biochemical and functional studies involving 
substituted peptides of T cell determinants and the re- 
cently described crystal structure of the influenza hemag- 
glutinin (HA [306-318])-DRl complex have allowed the 
identification of the main features of peptide binding to 
MHC class II molecules and its subsequent recognition 
by the TCR (Allen et al., 1987; Fox et al., 1987; Evavold 
et al., 1992; Reay et al., 1994; Stern et al., 1994). Many 
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Figure 3. The PL.17 Thl Clone Response to 
Multisubstituted Peptidesof the Hb@4-76) De- 
terminant 
(A) Proliferative response to Ala-substftuted 
peptides. The extended length for the peptides 
was chosen to correspond more closely with 
the HA@%-316)IDRl determinant, for which 
a crystal structure has been determined. No 
difference was observed in the T cell response 
to Hb(65-76) and Hb@4-76). For the initial sub- 
stitutions, Ala (A) residues were inserted at 
amino acid positions 65,66,67,71,74,77, and 
76 (Hb[65-761 plus 7A). Insertion of an Ala at 
position 73 increased the prollferatfve re- 
sponse (Hb[65-76) plus 6A). The Lys (K) at po 
sition 65 was not necessary for the T cell re- 
sponse, but was retained to improve the 
solubility of the synthesized peptides (Hb[65- 
761 plus 7A, K65). 
(B) Summary of T cell profiirative and apop 
tosis response to highly homologous Hb pep 
tides. The concentration (micromolar) of pep- 
tide required to induce 50% apoptosis (partial 
agonist) and proliferation (agonist) is shown. 
Peptideswereusedatconcentrationsup to 100 
pM. The values represent the mean of tripficate 
determinations and have been confirmed in at 
least four separate experiments. As these peptide lengths showed no effect on the T cell response, 12-mers were used, corresponding to amino 
acids 85-76. In addition to the Ala substitutions, the secondary TCR substitutions were T to S69, A to M70, and L to W5. The I-E anchor changes 
were I to L66, L to R76, and G to S74. Replacement with a Gln at position 72 (Q72) failed to stimulate any T cell response. 
T cell responses appear to focus on a single amino acid 
residue of the antigenic peptide, termed a primary T cell 
contact, and less intensely on other TCR contact residues, 
termed secondary contact residues. The results from our 
studies of the Hb(84-78)/l-Ek determinant and those of the 
extensively characterized moth cytochrome (93103)/l-Ek 
determinant have allowed a provisional assignment of the 
TCR and MHC contact residues for the Hb peptide (Eva- 
vold et al., 1992; Reay et al., 1994; Sorger et al., 1990) 
(Figure 2). These two non-cross-reactive determinants 
have many similarities including the I-Ek binding motif, 188 
and K78 (Figure 2). For the Hb(84-78) determinant, 5 aa 
have been identified as important for T cell activation, 
namely positions 89, 70, 72, 73, and 75, with N72 being 
the primary T cell contact residue (Evavold et al., 1992). 
In our previous studies, we had shown that altered peptide 
ligands could be generated by substitution of a secondary 
TCR contact residue. These assignments of TCR and 
MHC binding residues for the Hb(84-78) determinant pro- 
vided us with a template to identify systematically the pa- 
rameters for recognition of agonists or partial agonists. 
Rules Governing TCR Recognition of Ligand 
To generate rules for TCR recognition of the Hb@4-78) 
determinant, peptides were synthesized containing multi- 
ple amino acid substitutions. The initial experiments were 
focused on amino acid positions expected to change the 
T cell response minimally. For the first peptides, the index 
Hb sequence (Hb[84-781) was shifted to (Hb[85-781) to 
match more closely the length of the crystallized peptide- 
DRl complex (Stern et al., 1994). These changes did not 
alter peptide affinity for the MHC molecule or the T cell 
proliferative response (Figure 3A; data not shown). Next, 
Ala substitutions were introduced at 7 aa positions (85, 
88,87,71,74, 77,78) in the peptide, resulting in identical 
T cell proliferative responses (Hb[85-781 plus 7A). The 
addition of another Ala at position 73 led to peptide that 
contained only 50% of the original residues yet had an 
improved abilitytostimulate aPL.17proliferativeresponse 
(Figure 3; [Hb(85-78) plus 8A]). As this peptide was less 
soluble than the native sequence, the Lys (K) was rein- 
serted at position 85 to improve the solubility (Hb[85-781 
plus 7A, K85). 
In the next phase of experiments, the PL.17 Thl clone 
was found to respond to a peptide containing a single 
amino acid from the Hb(84-78) sequence. This peptide 
was derived by altering the amino acids at the secondary 
T cell contact and the I-Ek anchor residues. The peptide 
template contained multiple Ala’s with the reinsertion of 
a Lys at position 85 and a Gly at position 74 (Figure 38). 
The replacement of the secondary T cell contact residues 
(89, 70, 75) into this template generated a peptide that 
retained agonist (proliferative) activity (Figure 38, second- 
ary TCR). The amino acids employed were selected from 
those that allowed a productive interaction when changed 
individually in the immunogenic peptide (see Figure 2 leg- 
end). Further modifications were made by conservatively 
substituting the amino acids that constitute I-Ek anchor 
and binding residues (188,674, K78)(Leighton et al., 1991; 
Reay et al., 1994; Evavold et al., 1992). Peptide affinity 
is not affected by conservative amino acid substitutions 
at these residues (Evavold et al., 1992). Interestingly, this 
peptide was classified as a partial agonist for the PL.17 
clone using the apoptosis assay, even though it contained 
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Figure 4. The Fetal y2 Hb@4-76) Peptide Containing the Primary T 
Cell Contact Residue N72 Activates the PL.17 Clone 
The apoptosis assay was performed as described in Figure 1. The 
peptide sequences used for the apoptoeis assay were the following: 
Hb(64-76) GKKVITAFNEGLK; fetal y2 Hb@4-76), GKKVLTAFGE- 
SIK; N72-fetal y2 Hb(64-76) GKKVLTAFNESIK; S70, GKKVITSF- 
NEGLK; H70. This experiment is representative of five separate deter- 
minations. The values represent the mean of duplicate determinations 
with the standard deviations for each point comprising <lo% of the 
mean value. 
only 1 aa in common, the primary T cell contact residue 
(N72), with the native antigen (Figure 38, I-E anchor, I-E 
anchor plus A65). The substitution of the primary T cell 
contact residue with a Gln (Q72) in this peptide or the 
peptide containing altered 6eCOndary TCR contact resi- 
dues completely abrogated any T cell response (Figure 
38). Again, the amino acid at position 65, Ala or Lys, had 
no effect on the T cell response (I-E anchor plus A65). 
Thus, the generation of agonist and partial agonist ligands 
for a Hb(64-76)specific Th cell required only the primary 
T cell contact residue, along with selected amino acids at 
the secondary T cell contacts and MHC binding sites. 
A confirmation of the requirement for the primary TCR 
contact residue was supplied by manipulation of the pep- 
tide corresponding to Hb(64-76) from the fetal y2 hemo- 
globin sequence (Figure 4). This peptide was inactive as 
an agonist or partial agonist, although it only differed by 
4 aa from the immunogenic peptide (positions 66,72,74, 
and 75). Separately, each of the amino acid substitutions 
at positions 66,74, and 75 are acceptable for peptide rec- 
ognition by the PL.17 TCR (see Figure 2; Evavold et al., 
1992). The simple replacement of an N for the G at position 
72 converted the fetal Hb peptide into a partial agonist 
(Figure 4), and induced an apoptotic response similar to 
the S70 partial agonist. The classification of the N72 fetal 
peptide as a partial agonist was confirmed by its failure 
to induce a proliferative response (data not shown). This 
partial agonist peptide now contained the primary T cell 
contact residue, N72, along with permissible amino acids 
at the secondary Tcell contact (75) and MHC binding sites 
(66 and 74). 
Identification of Endogenous Agonlst or Partial 
Agonist Peptldes 
Having established the rules for recognition of the Hb(64- 
76)/l-Ek determinant by the PL.17 TCR, the SwissProt da- 
tabase was searched for natural agonists or partial ago- 
nists using the criteria that the peptide must contain the 
Hb(M76) 
NOS 
NCad 
Qn 
Log Peptide Concentration (PM) 
Figure 5. Search of SwissProt Database Identifies Activating Ligands 
for the PL.17 Thl Clone 
(A) Summary of searches, the peptides identified, and their abitii to 
stimulate PL.17 or 3.L2 T cells. The Geneworks program (Intelligene- 
tics) was used to search the SwissProt database (release 26). For the 
searches, the native endcgenws Hb amino acid plus sefected amino 
acids were used for a given position. In Search I, the spaclfted amino 
acids for each amino acid position were 66, ILYFWA; 69, TSPF; 70, 
ATCIGMS; 71, FAYLI; 72, N; 73, EDASQ; and 74, G. For Search 2. 
the selected amino acids were 72, N; 73. EDASQ; 74, 0; and 76, 
KRI. The peptides were derived from the sequences of the followtng 
proteins: NOS, rat brain nitric oxide synthase; Fas, rat fatty acfd syn 
thase; Cyph, mouse cyclophilin; Thil, rat acetylCoA acetyltransferase; 
NCad, mouse NCadherin; Kfak, mouse focal adhesion kinase; Fgrl, 
mouse basic fibroblast growth factor receptor I; Plap, mouse phospho- 
lip-A-2 activating protein; and Vcaml, mouse vascular cell adhe 
sion protein 1. The sequence numbers refer to the amino acid posttions 
of the entry as given in the SwissProt database. The activating peptides 
for PL.17 failed to activate apoptosis with the 3.L2 Thl clone as well 
as the Hb2 Thl and YOI .6 hybridoma (data not shown). The values 
represent the (ECd uhf concentrations of each of the peptktes. A dash 
indiMltes no activity at concentrations up to 100 pM. Each peptlde 
was tested in at least two different experiments for PL.17 and 3U. 
The values represent the mean from a single experiment. and Identical 
results were obtained in the other experiments. The posslbflky that 
the activities of the NOS and the NCad peptides were due to some 
other contaminating agonist introduced during the puriftcation pmce- 
dure was eliminated by demonstrating that unpuriffed peptides had 
identical activities. 
(B) PL.17 stimulated with the NOS or NCad peptide induced CH27 
apoptosis. CH27 plus PL.17 plus no antigen control was 19,662 cpm. 
From six separate experiments. the mean ECm value for tfte NCad 
peptide was 120 f 46 uh4. The values represent the mean of triplicate 
determinations, with thestandarddeviations being<lO%ofthe mean. 
primary Tcell contact residue(N72), specified secondaryT 
cell contacts, and selected I-E’anchor residues. All rodent 
proteins, excluding hemoglobin or related sequences, 
were involved in the searches to maximize the size of the 
database. In one search, 10 of 3176 rodent sequences 
satisfied the search criteria (Figure 5A). of these peptides, 
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Figure 6. Induction of Thl Clone Proliferation or Anergy by the NOS 
or NCad Peptides 
(A) NOS peptide induced proliferation in the PL.17 Thl clone. 
(B)The NCad partial agonist can induceanergy in the PL.17Thl clone. 
The S70 peptide (GKKVITSFNEGLK), a known partial agonist, was 
the positive control for anergy induction, and the H70 peptide 
(GKKVITHFNEGLK), a known null peptide, sewed as the negative 
control. All peptides were used at 100 pM, except NCad. which was 
also tested at 200 pM. The NCad(200) and NCad(lO0) refer to the 
NCad peptide used at 200 pM and 100 FM, respectively. The NCad 
peptide in the absence of APCs was not toxic or inhibitory to the PL.17 
ceils. The values represent the mean of triplicate determinations from 
the cultures stimulated with 1 .O pM of Hb(64-76) with the standard 
deviation being <15% of the mean. 
four were synthesized and, remarkably, a sequence corre- 
spondingtorat brain nitricoxidesynthase, NOS(205-216) 
that shared only 4 aa with Hb(64-76) was an agonist for 
the PL.17 clone (Figure 58). Additional searches were per- 
formed using various combinations of the secondary and 
MHC binding residues. From a search focused on the 
C-terminal amino acids of the Hb peptide, 5 of 14 potential 
sequences were synthesized (Figure 5A), and a partial 
agonist was identified (Figure 58). This sequence was de- 
rived from the N-Cadherin protein, NCad(630-641) a neu- 
ronal Ca%dependent intercellular adhesion molecule (Mi- 
yatani et al., 1994). Thus, two activating ligands were 
identified from the potential endogenous peptide reper- 
toire for the PL.17 Thl clone. 
The NOS(205-216) and the N-Cadherin peptides were 
also tested in proliferation or anergy assays to corroborate 
the apoptosis data. As expected, the NOS(205-216) pep- 
tide induced T cell proliferation, confirming its classifica- 
tion as an agonist for the PL.17 clone (SA). The N-Cadherin 
peptide acted as a partial agonist, since it failed to stimu- 
late a proliferative response but induced an anergic state 
in the PL.17 Thl clone similar to the S70 partial agonist 
(Sloan-Lancaster et al., 1993) (Figures 6A and 6B). The 
requirement for the primary TCR contact residue in the 
NCad(630-641) peptide was confirmed by generating a 
peptide with an N to Q substitution at position 637, which 
completely lacked any stimulatory activity (data not 
shown). 
Specificity of T Cell Response 
to Endogenous Peptldes 
Although these data show the recognition of multiple li- 
gands by the TCR, exquisite specificity was also present 
as neither of the endogenous activating peptides, 
NOS(205-216) or NCad(630-641) stimulated another Hb- 
specificTcellclone,3.L2(seeFigure5A),norotherHb@l- 
76)-specific T cell clones and hybrldomas (data not shown). 
This specificity must result from the unique spectrum of 
secondary T cell contacts and MHC binding residues criti- 
cal for each individual TCR (Evavold et al., 1992). This 
indicates that there is flexibility in the conformation of 
some of the side chains in peptides bound to class II mole- 
cules, as has been shown for peptides bound to class I 
molecules (Madden et al., 1992). It would also explain the 
inability of the 7 other peptides identified in the database 
search to stimulate PL.17. 
Discussion 
The studies reported here identify the rules that govern 
TCR recognition of antigen and provide evidence for the 
existence of multiple different ligands for an individual 
TCR in the endogenous peptide repertoire. These findings 
clearly show that a single amino acid, when placed in the 
proper context of other amino acids at the secondary TCR 
contact and MHC binding residues, can result in two non- 
homologous peptides able to stimulate the same T cell. 
The apoptosis assay was a critical component for identi- 
fying the peptide features found in agonists and partial 
agonists. In our previous studies, partial agonists were 
identified by their failure to induce T cell proliferation while 
stimulating selective T cell functions (Evavold and Allen, 
1991; Sloan-Lancaster et al., 1993, 1994b; Evavold et al., 
1993c). For example, in the Th2 clone 2.102, the D73 pep- 
tide induced significant levels of interleukin-4 (IL4) pro- 
duction, yet it failed to induce any proliferation of the 2.102 
T cells, even when given at 1 06-fold higher concentration 
than that required to observe proliferation with the Hb@4- 
76) peptide (Evavold and Allen, 1991). This and our subse- 
quent studies indicated that the partial agonists differed 
qualitatively from the agonists in delivering the signals for 
a T cell proliferative response; however, in the functional 
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assays of B cell help, cytolysis, and now apoptosis, the 
partial agonists differed quantitatively from the immuno- 
genic peptide. This may be explained if TCR engagement 
of peptide-MHC complexes can stimulate apoptosis, or 
other functions, but not all of the T cell signals required 
for proliferation. Qualitative differences between partial 
agonists and agonists has recently been described for 
some T cell signaling events (Sloan-Lancaster et al., 
1994b). Thus, the apoptosis assay identifies partial ago- 
nists, as do the B cell help, cytolysis, or anergyassays, with 
the added advantages of being more rapid and sensitive. 
The data presented here also highlight the complexity 
in separating the effects of MHC binding and secondary 
T cell contact residues on T cell stimulation. Alteration of 
MHC binding residues can at times change the effective 
concentration of ligand available to the TCR and the po- 
tency of the T cell response. The differences in potency 
relate to the quantity of ligand available to interact with the 
TCR. Such peptides differ from the immunogenic peptide 
only in the effective concentration required for the T cell 
responses, and are therefore distinct from the partial ago- 
nists. For peptides that interactwith the MHC class II mole- 
cule, most amino acid substitutions fail to alter the overall 
affinity, as the “pockets” of the MHC class II molecule are 
usually permissive to many amino acids. This has been 
extensively investigated in the related cytochrome c-I-Ek 
model antigen, where each naturally occurring amino acid 
has been replaced at every position in the peptide and its 
effect on binding to the I-Ek was ascertained (Reay et al., 
1994). MHC class II-restricted peptides may also be less 
sensitive to affinity differences as a result of multiple con- 
sewed interactions between the main chain of the peptide 
and the MHC class II molecule. Although the alteration of 
MHC binding residues usually generates peptides with 
similar overall affinities, they can sometimes result in dif- 
ferent T cell responses (Reay et al., 1994; Stern et al., 
1994) (Figure 3). This would suggest that the altered MHC 
contact residues are inducing subtle changes in the pep- 
tide conformation, which affect the TCR contact residues 
and resulting T cell response. These subtleties may con- 
tribute to the observation that not all peptides that followed 
the selection criteria activated the PL.17 clone. 
Using our established Hb(64-76) system, we have mod- 
eled the TCR recognition of this antigen as focusing on 
a primary TCR contact residue and, to a lesser extent, on 
secondary TCR contact residues. Other well-defined Tcell 
epitopes, including the moth cytochrome c 91-103/l-Ek 
antigen (Reay et al., 1994; Jorgensen et al., 1992) (Figure 
2)and the HA(306-316)IDRl (Rothbardet al., 1966,1969), 
can be similarly modeled. Interestingly, the alignment of 
the major MHC anchor residues (moth cytochrome c, 95, 
103; HA, 306,319 and Hb, 66,76) also results in the over- 
lay of the putative primary TCR contact residue (moth cyto- 
chrome c, 99; HA, 312; and H b, 72). In the crystal structure 
data, the HA 312 residue was the only amino acid pointed 
directly toward the site of TCR interaction without having 
any contact with the DRl molecule, supporting its designa- 
tion as a primary TCR contact residue. Although these 
well-characterized epitopes support our model of TCR in- 
teraction with peptide, similar types of analyses need to 
be done with other determinants to confirm this hierarchy 
in the recognition of TCR contact residues. 
In these studies, we were able to identify potential en- 
dogenous agonists and partial agonists by searching the 
SwissProt database, and synthesizing candidate pep 
tides. Although we have not shown that these endogenous 
ligands are actually generated in vivo, the success in find- 
ing agonists or partial agonists contained within the small 
sample of rodent proteins (total = 3,176) indicates that 
their existence in the pool of 59006-70600 expressed 
self-proteins is highly probable. These findings would 
strongly imply that any individual T cell would have multiple 
potential different ligands in the endogenous peptide rep 
ertoire. The actual identification of a naturally occurring 
agonist or partial agonist must come from biochemical 
studies in which the peptides are eluted from the class II 
molecules and the sequences identified (Rudensky et al., 
1991a, 1991b; Hunt et al., 1992; Chiczet al., 1992). Such 
studies estimated that class II molecules express approxi- 
mately 1 ,OOO-2,000 different peptides, with some being 
more abundantly represented than others. If a naturally 
occurring agonist or partial agonist was one of the domi- 
nantly represented peptides, its identification would be 
greatly facilitated; however, the extreme sensitivity of the 
immune system also allows less frequently expressed 
peptides to play an important functional role. An advan- 
tage of our model using the apoptosis assay is that it allows 
for the identification of possible endogenous epitopes that 
could be immunologically important, but expressed at lev- 
els lower than could biochemically be detected. 
The existence of multiple endogenous ligands for any 
given TCR have direct implications for T cell development 
in the thymus and for peripheral T cells. The features de- 
scribed here for peptide recognition are essential for posi- 
tive selection, because the potential pathogens that the 
immune system is designed to recognize will not exist in 
an animal during T cell development. Thus, as has been 
previously proposed, positive selection would result from 
the recognition of a peptide from the endogenous peptide 
repertoire (Sprent et al., 1966; Marrack and Kappler, 1966; 
Matzinger and Bevan, 1977; Mannie, 1991; Janeway et 
al., 1992; Ashton-Rickardt and Tonegawa, 1994). The self- 
antigenic determinant must look enough like the unknown 
foreign antigen to the TCR to allow for positive selection, 
but not be of too high avidity to result in negative selection 
(Janeway et al., 1992; Ashton-Rickardt and Tonegawa, 
1994). The N-Cadherin partial agonist identified here could 
potentially be involved in the development of T cells such 
as PL.17, since N-Cadherin is expressed in myoblasts 
(Knudsen et al., 1990), which can be found in the thymus 
(Kao and Drachman, 1977). 
Surh and Sprent (1994) have clearly demonstrated that 
the majority of T cells die in the thymus due to lack of 
positive selection, indicating that negative selection is not 
responsible for the bulk of thymocyte death. Self-peptides 
are likely candidates to play a role in positive selection, 
and recent observations have indicated that peptides with 
high homology to the immunogen can drive positive selec- 
tion in fetal thymic organ culture models (Hogquist et al., 
1994; Ashton-Rickardt et al., 1994; Sebzda et al., 1994). 
B&&rum of Ligands Recognized by a TCR 
While very similar peptides can support positive selection, 
the noninterference model of thymocyteselection hassug- 
gested that much less peptide specificity is required by 
the TCR (Schumacher and Ploegh, 1994). In this model, 
peptide functions to maintain the MHC structure, and posi- 
tive selection occurs with any peptide in which the amino 
acid side chains do not interfere with the interaction be- 
tween the TCR and the MHC molecule. Our results are 
compatible with both the fetal organ data and the noninter- 
ference model in that a given TCR can specifically interact 
with ligands containing multiple amino acid substitutions 
at many of the TCR contact positions, predicting that multi- 
ple endogenous peptides could positively select the same 
TCR. It should be noted that most positive selection stud- 
ies have examined class l-restricted systems, while our 
studies have examined a class II response. Differences 
may exist between the two regarding the recognition of 
ligand and the number of potential endogenous ligands. 
This is most certainly apparent in the size and nature of 
the peptide that interacts with their respective MHC mole- 
cules. Peptides presented by MHC class II molecules are 
longer and contain more potential points of interaction with 
the MHC-binding groove, which would tend to minimize 
the effects of amino acid substitutions on overall affinity 
and the resultant ligand concentration. 
The peripheral T cells would be similar to thymocytes 
in that they must also be confronted with a continuum of 
ligands. An obvious complication from the recognition in 
the periphery of ligands used for positive selection would 
be unwanted T cell activation. Such a problem could be 
overcome if mature naive T cells could ignore these li- 
gands in the periphery by being less sensitive to them 
than thymocytes. In support of this are two recent studies 
concerning the development of mature CD& or CD4- 
restricted T cells. Jameson et al. (1994) report that CD8 
expression was decreased to prevent peripheral full reac- 
tivity to the positive selecting ligands, and our recent ob- 
servations on CD4 T cell development in vivo revealed 
that an endogenous antagonist expressed in the thymus 
eliminates the higher avidity T cells (Hsu et al., 1995). 
Alloreactivity represents another peripheral T cell re- 
sponse in which T cell avidity for ligand may play a role 
(Sherman and Chattopadhyay, 1993; Bevan, 1984). The 
potent T cell response to alloantigens can be addressed 
by the TCR possessing a broad but specific capacity to 
interact with a spectrum of ligands. In most models of 
allo-reactivity, peptide specificity can be demonstrated in 
the T cell response (Guimezanes et al., 1992; Sherman 
and Chattopadhyay, 1993). We would expect T cells to 
respond to any allo-peptide that bound the allo-MHC class 
II molecule and expressed the proper primary and second- 
ary TCR contact residues. In addition, the observed high 
precursor frequency and T cell response to allo-ligands 
could result from the thymocytes not having had their avid- 
ity dampened by selection in the thymus. Overall, T cell 
avidity may be an important control mechanism for periph- 
eral T cell responses. 
Despite such tuning of the reactivity, a productive T cell 
interaction with different ligands may be important for the 
immune response. Recent studies suggest that T cells 
that have previously interacted with antigen can recognize 
a wider variety of ligands (Severley, 1999; Lau et al., 1994). 
This would allow memory cells to react with related patho- 
genic epitopes as was observed in the lymphocytic chorio- 
meningitis virus system and thereby expand the T cell 
response(Selin et al., 1994). Besides possible interactions 
with environmental antigens, the self-peptides may be an 
important mechanism for maintaining T cell memory in 
the absence of persistent antigen. Thus, the potential of 
the TCR to interact with multiple endogenous and foreign 
types of ligands throughout its life span has important con- 
sequences for T cell biology. 
ExPerImental Proceduree 
Celk and Reagents 
The CH27 B cell lymphoma, the PL.17 Thl clone, and the 3.i2 Thl 
clone were grown in RPM1 1640 medium supplemented with 10% fetal 
calf serum (Hyclone), 50 &ml gentarnicin, 2 mM Glutamax (GIBCC), 
and 2 x lo* M 2-ME as previously described (Lorenz and Allen, t969; 
Evavotd et at., 1992, 1993a). In brief, the CH27 cells are an H-2“ B 
cell lymphoma that expresses the I-EVI-Ak MHC class II molecules, 
ICAM-I, and 87 costimulatory molecules. The PL.17 Thl clone is spe 
cific for a peptide fragment from the 5 minor chain of murine Hb@4- 
70) as presented by the I-f? MHC class II molecule. Peptfdes were 
synthesized using either an ABI Model 432 or an Advanced ChemTech 
Model 350 peptide synthesizer, purified by reverse-phase high pres- 
sureliquid chromatography, and analyzed for amino acid content and 
concentration (Beckman Model 6300 amino acid analyzer). 
Apaptoois 
Apoptosis of the CH27 cells was assayed according to the technique 
of Matzinger (1991). In brief, CH27 cells (2-4 x l-0”) were radiolabeled 
using 4 uCi PH]thymidine incubated for5 hr in 1 ml of RPM1 1640 media 
(seeabove). Cellswerewashedtwicebeforeuseasantigen-presenting 
cells (APCs). The cultures contained CH27 cells (3 x IO’), PL.17 
(3 x IO’), and the indicated peptides. After 24 hr, the cultures were 
harvested (Bkatrcn)ontoglassRltero(Phannacia) for liquidscintillation 
counting (Betaplate Pharmacfa). Apoptosis was conffrmed by agarose 
gel electrophoreses. CH27 (1 x lq and PL.17 (1 x IO? cells were 
cultured for 24 hr with or without 10 uM Hb(64-76) peptide. Cells 
were lysed with 1% Trfton and DNA separated by centrifugation as 
described (Duke and Cohen, 1994) Fragmented DNA was contained 
in the soluble fraction; intact DNA in the pellet. of each sample 10 pl 
was analyzed using a 1% agarose gel buffered in 10 mM Tris, 1 mM 
EDTA (pH 7.5). In Figure 1, lane I, the molecular weight standards 
(1 kb ladder, GIBCO) and their indicated size in kb are shown. 
T Cell Assays 
T cell proliferation assay was done as described (Evavold et at., 1992). 
Thl clone cells (3 x 1OVwell) were cultured with a source of APCs 
(5 x 106 cells/well irradiated BlO.BR sptenocytes) and the indicated 
concentration of peptide for 3 days. Protiferation was assessed by 
inclusion of [BHjTdR (0.4 @Xwell) included for the final 20 hr. The 
protocol for induction of anergywas performed as previously described 
(Sloan-Lancaster et at., 1993). In brief, PL.17 T cells (5 x 106) and 
mitomycin o-treated DCEK Hi7 APC (5 x 1gVwell) were incubated 
atone (no peptide) or with the indicated peptides for 20 hr. The T cells 
were then separated from the APC, and challenged in a proliferation 
assay using irradiated BlO.BR sptenocytes as APCs and Hb(64-76) 
(0.1-10 PM) as the antigen. The cells were harvested after 72 hr of 
culture, with PH)TdR (0.4 uCi/well) included for the final 20 hr, and the 
level of PHjTdR incorporation detected as a measure of proliferation. 
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